Investor's Business Daily on MSN

Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates

Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 ...